The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The long-lasting anti-tumor activity of cisplatin affecting the sustainable systemic immune alteration may improve distant-disease free survival of triple-negative breast cancer in patients with a substantial residual tumor following preoperative chemotherapy: A retrospective analysis with translational research.
 
Ayane Yamaguchi
No Relationships to Disclose
 
Kosuke Kawaguchi
No Relationships to Disclose
 
Hiroshi Ishiguro
Research Funding - Taiho Pharmaceutical
 
Tatsuki R Kataoka
No Relationships to Disclose
 
Masae Torii
No Relationships to Disclose
 
Chenfeng He
No Relationships to Disclose
 
Nobuko Kawaguchi-Sakita
No Relationships to Disclose
 
Masahiro Kawashima
No Relationships to Disclose
 
Masahiro Takada
Speakers' Bureau - AstraZeneca; Chugai Pharma; Eisai; Kiowa Kirin; Lilly; Nippon Kayaku; Pfizer; Takeda
Research Funding - AstraZeneca; Daiichi Sankyo; Eisai
 
Eiji Suzuki
No Relationships to Disclose
 
Masakazu Toi
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Genomic Health; Konica Minolta; Kyowa Hakko Kirin; Lilly; Novartis; Pfizer; Shimadzu; Taiho Pharmaceutical; TAKEDA; Yakult Pharmaceutical
Consulting or Advisory Role - Daiichi Sankyo; Konica Minolta; Kyowa Hakko Kirin
Speakers' Bureau - AstraZeneca; Lilly; Pfizer
Research Funding - AFI technology; Astellas Pharma; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Japan Breast Cancer Research Group; Kyoto Breast cancer Research Network; Nippon Kayaku; Ono Pharmaceutical; Pfizer; Shimadzu; Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - JP 2017-143763 WO2017/131162A1 (Inst); PCT/JP2016/004374 (Inst)
Travel, Accommodations, Expenses - Eisai; Takeda
Other Relationship - Japan Breast Cancer Research Group; Japan Breast Cancer Research Group; Kyoto Breast Cancer Research Network; Organization for Oncology and Translational Research